Syngene reports 13% sequential revenue growth in second quarter
By United One News · AI-generated summary of 2 outlets' reporting
Published · Updated
AI-generated summary of the coverage listed below:
Syngene reported 13 percent sequential revenue growth during the second quarter of fiscal year 2027.
- Operating EBITDA rose to Rs 147 crore in Q2 FY27.
- EBITDA increased from Rs 91 crore in the preceding quarter.
Covered by 2 outlets across the spectrum: 0% left, 100% center, 0% right.
How each side framed it
Syngene posts 13% sequential revenue growth in Q2
Timeline
First to report: indianpharmapost (); 2 articles from 2 outlets so far.
Who is covering this story
- Center (2): indianpharmapost, Seeking Alpha
Sources
- Syngene posts 13% sequential revenue growth in Q2 — indianpharmapost (center, AI-estimated) ·
- Richards Group Q3 revenue growth driven by acquisitions — Seeking Alpha (center, AI-estimated) ·